AI-generated draft from CMS source. Review and verify clinical accuracy before use.
CLINICAL STAGE / CARE PATHWAY
Patient is currently in the therapeutic intervention phase following documented chronic severe peripheral nerve pain lasting at least 3 months that is refractory to conservative care. Clinical findings and diagnostic correlation support progression to open implantation of a neurostimulator electrode array targeting the identified peripheral nerve distribution. Prior successful trial stimulation producing at least 50% pain reduction informs readiness for permanent implantation.
– Sequencing logic:
Begin with exhaustive conservative treatment including medication management and physical therapy. Proceed to a temporary neurostimulator trial demonstrating ≥50% pain relief before considering open implantation of the permanent device.
ICD-10 / DIAGNOSIS SUPPORT
Diagnosis support includes chronic neuropathic pain conditions such as complex regional pain syndrome, post-surgical peripheral nerve injury, causalgia, occipital neuralgia, and painful mononeuropathy consistent with the planned peripheral nerve stimulation intervention.
The documented diagnosis correlates with the patient's clinical presentation, prior treatment failure, and diagnostic studies confirming the peripheral nerve as the pain generator.
– Example ICD-10 options:
G56.41 – Causalgia of right upper limb
G57.71 – Causalgia of right lower limb
G90.511 – Complex regional pain syndrome I of right upper limb
M62.85 – Dysfunction of the multifidus muscles, lumbar region
G54.1 – Lumbosacral plexus disorders
SUBJECTIVE / HPI SUPPORT
Patient reports chronic, severe neuropathic pain localized to the peripheral nerve distribution with functional limitations including reduced walking, standing, and activities of daily living despite comprehensive medication management and non-invasive therapies over at least 3 months.
– Edit if needed:
post-surgical neuropathic pain
complex regional pain syndrome
occipital neuralgia
painful mononeuropathy
greater than 3 months
CONSERVATIVE CARE / PRIOR TREATMENT
Patient has undergone a documented trial of conservative treatment including physical therapy, medication management (NSAIDs, neuropathic agents), psychological assessment, and other less invasive interventional treatments without adequate or sustained pain relief or functional improvement.
– Common conservative care examples:
Formal physical therapy
Medication management including neuropathic pain agents
Psychological therapy and screening
Activity modification
Prior injection therapy
– Documentation tip:
Include duration and specific modalities attempted with patient response.
OBJECTIVE / DIAGNOSTIC SUPPORT
Physical examination and diagnostic studies support localization of the pain generator to the peripheral nerve targeted for stimulation. No contraindications such as active infection or significant medical comorbidities are identified.
Documented successful temporary PNS trial with greater than or equal to 50% reduction in pain intensity and functional improvement over the trial period.
ASSESSMENT
Assessment: Persistent chronic neuropathic pain localized to a defined peripheral nerve distribution with documented functional impairment and failure of conservative care. Clinical findings and diagnostic correlation support medical necessity for open implantation of a neurostimulator electrode array to achieve durable pain relief and improve function.
PLAN / NEXT STEP
Plan: Proceed with open implantation of peripheral nerve neurostimulator electrode array targeting the painful nerve distribution. Patient has demonstrated adequate response to prior trial stimulation. Risks, benefits, and alternatives have been discussed and documented.
– Edit if needed:
right-sided
left-sided
bilateral
upper extremity
lower extremity
occipital nerve
median nerve
sciatic nerve
PROCEDURE-SPECIFIC CLINICAL REQUIREMENTS
Patient has undergone a PNS trial with documented ≥50% pain reduction and functional improvement supporting progression to permanent implantation. No active infection or surgical contraindications are present. Psychological screening documented with no contraindications.
– Documentation tip:
Include pre- and post-trial pain scores, trial duration, percentage relief, and functional assessment.
FOLLOW-UP / RESPONSE DOCUMENTATION
Post-procedure follow-up will monitor for sustained pain relief, functional improvement, and any device-related complications. Patient education on device use and potential risks has been provided.
– Edit if needed:
greater than 50% improvement
follow-up at 3 months
monitoring for device migration or infection
functional gains in ADLs
MISSING DOCUMENTATION CHECK
– Documentation items to confirm:
Symptom duration ≥3 months
Functional limitation and impact on ADLs
Prior comprehensive conservative treatment modalities
Psychological screening
Successful trial stimulation with ≥50% pain relief
Imaging or diagnostic correlation confirming pain generator
Pre- and post-trial pain scores
Clinical exam confirming target peripheral nerve
Absence of contraindications
Planned anatomical target and laterality
Diagnostic evidence supporting neuropathic pain diagnosis
APPEAL / PEER-TO-PEER CLINICAL SUPPORT
The requested open peripheral nerve stimulation implantation is clinically supported by persistent chronic severe neuropathic pain refractory to conservative management, documented successful trial stimulation with significant pain reduction, and appropriate patient selection based on diagnostic correlation and psychological evaluation. The care pathway aligns with evidence-based indications supporting medical necessity for proceeding with permanent implantation.
COVERED PROCEDURES AND SERVICES
Peripheral nerve stimulation (PNS) is covered for relief of chronic intractable pain after failure of conservative treatments (medications, physical therapy, psychological therapy, and other less invasive interventions). Coverage applies to open or percutaneous lead placement near a peripheral nerve. Trial stimulation must precede permanent implant placement. Peripheral nerve field stimulation (PNFS) is not covered for any condition.
CPT/HCPCS CODES
Covered codes include percutaneous and open implantation of neurostimulator electrode arrays (e.g., 64553, 64555, 64561, 64575, 64581), revision/removal codes (64569, 64570, 64585, 64595, 64598), and insertion/replacement of pulse generators (64590, 64596, 64597). PNFS requires billing with unlisted CPT code 64999 and detailed narrative for denial. Class III FDA devices (product classification QLK) should be billed under 64555 and 64590 with ICD-10-CM code M62.85.
MEDICAL NECESSITY AND DIAGNOSTIC REQUIREMENTS
Patients must have documented chronic severe pain ≥3 months, failed all less invasive treatment modalities, lack surgical contraindications, have no active substance abuse, undergo formal psychological screening, and demonstrate at least 50% pain reduction during trial stimulation before permanent implant. Trials not meeting success criteria generally preclude permanent implantation unless justified by extenuating circumstances (e.g., equipment failure). Documentation must support device placement, patient selection, and medical necessity.
FREQUENCY AND UTILIZATION LIMITS
No more than two percutaneous implantations of electrode arrays (code 64555) are expected to be billed per 365 days. Trials are limited to four leads with a maximum of 16 contacts.
MODIFIERS AND BILLING REQUIREMENTS
For PNFS (non-covered), bill CPT 64999 with one unit of service, include procedure description and trial or permanent status in the claim narrative or comment fields: Loop 2400 or SV101-7 for electronic Part B; Item 19 for paper claims; SV02-7 for Part A electronic claims; Block 80 on UB04 for Part A paper claims.
PROVIDER QUALIFICATIONS AND SETTING
Temporary PNS trials may be performed in office if surgical support, sterility, equipment, and trained personnel are available. Permanent implants must be placed in ambulatory surgical center or hospital settings. Physicians conducting office trials must have like privileges in ASC or hospital or be board certified/eligible in Pain Medicine, Orthopedic Surgery, Neurosurgery, or equivalent per state regulations. It is preferred the same physician performs both trial and permanent implantation; if not, documented patient notification and referral information are required.
DOCUMENTATION EXPECTATIONS
Full documentation must support chronic pain diagnosis, prior treatment failures, trial success (≥50% pain relief or medication reduction plus functional improvement), imaging confirming proper lead placement, provider qualifications, and medical necessity criteria. Low trial-to-permanent implant conversion rates (<50%) will prompt post-payment reviews and documentation requests; failure to supply may result in denials and recoupment.
COVERAGE EXCLUSIONS AND DENIAL RISKS
PNFS/PSFS is not covered for any condition. Conditions lacking peer-reviewed evidence for PNS include fibromyalgia, phantom limb pain, diffuse polyneuropathy, nociceptive trunk or low back pain, and angina pectoris—claims will be denied as not reasonable and necessary. Repeat PNS trials are generally not covered unless justified by extraordinary reasons documented in the medical record.
CONSERVATIVE CARE EXPECTATIONS
Documentation of prior noninvasive treatments and medication management attempts is required before trial implantation authorization.
IMAGING GUIDANCE
Imaging guidance is expected when performed and should be documented to support placement accuracy.
ANESTHESIA AND SEDATION
Not clearly stated in source.
REPEAT PROCEDURE REQUIREMENTS
Repeat trials only with documentation of extenuating circumstances affecting initial trial.
RELATED DOCUMENTS
LCD L34328 v44 governs medical necessity, selection criteria, provider qualifications, and utilization limits. Article A55530 provides billing and coding instructions.
COMMON DENIAL PATTERNS
– Lack of documented trial success ≥50% pain reduction
– Failure to document prior conservative treatment attempts
– Inadequate provider qualifications or credentialing in office-based trials
– Billing PNFS under covered CPT codes without proper unlisted code 64999 and narrative
– Repeat trial without documented extenuating circumstances
This operational guidance is effective as of 10/23/2025 per CMS and Noridian's policy updates.